RxDoctor Payments Data

Nickolas Scherzer, MD

Urology · Pine Bluff, ARNPI 1790247542

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,375 of the $9,168 with a category attached, or 69.5%. 17 manufacturers reported payments, led by Boston Scientific at 35.7% of the total. 2025 is the largest year on record at $4,652, 3.5 times the $1,323 reported in 2021.

$9,168in general payments, 2019–2025

Across 117 payments — averaging $78.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Teleflex LLC$2K
  • Procept Biorobotics Corporation$2K
  • Coloplast$728
  • Medtronic$526
  • Axonics, Inc.$204
  • plus $488 from 11 others

What the payments were for

  • Travel & lodging$2,79230%
  • Food & beverage$6,37570%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,168 in reported general payments places this provider in the 60th percentile of 88 urology providers in Arkansas.

See all urology providers in Arkansas

Medicare billing

Part B allowed, 2024
$23,098
Medicare patients
82
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol27$1,668
Trospium Chloride14$806
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$219
Tamsulosin Hcl11$68

Paid to pharmacies, not to this prescriber.

Other urology in Pine Bluff

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →